Themis Medicare Ltd

Stage 2 · Advancing · week 14Setup 4.4 WatchSolid +1.0

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. More about the company

₹115.5
+1.74% today
₹1,073 Cr · Small cap
Market Neutral — FadingHealth Care 45.7% in Stage 2-1.4 pts / 20dPharmaceuticals 53.8%+3.8 pts
Loading price chart…
vs 52W High
-16.1%
₹66.1 lo₹137.7 hi
16.1% below 52W high — deeper pullback
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 14
1w13w26w
Week 14 — proven structure, sweet spot
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
14.6%
200 DMA: ₹100.8 · rising
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.29x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
MA20 rolling over · -3.3% vs MA50 +2.7%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-4.1%
3M
+3.2%
6M
+43.9%
YTD
+10.4%
1Y
-11.6%
Sector
Health Care
↓ Peaking
Stage 2%
45.7%
20d Δ
-1.4pp
1M return
-1.8%
3M return
+4.4%
Sector Stage-2 % · last 20 days
This stock ranks #68 of 77 Stage 2 stocks in Health Care by RS. Lagging sector peers.
Industry
Pharmaceuticals
↑ Building
Stage 2%
53.8%
20d Δ
+3.8pp
1M return
-0.9%
3M return
+3.6%
Industry Stage-2 % · last 20 days
Ranks #54 of 61 Stage 2 stocks in this industry.
Stage Cycle Timeline2023-07-12 → 2026-10-07
S2 19w
S2 26w
S4 33w
S4 20w
S2 14w
2023-07-122026-10-07
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 1w → S3 4w → S2 12w → S3 4w → S2 19w → S3 12w → S2 26w → S3 5w → S4 33w → S1 9w → S4 20w → S1 9w → S2 14w current
Total tracked: 168 weeks across 13 stage runs.
Scan Membership
Prop Scan
Latest: 2026-09-30
Pullback Hunter
Latest: 2026-08-07
Breakout Watch
Latest: 2026-06-30
50 appearances in last 60 days. First seen: 2024-07-18.
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-07S2
Wk 14 · Vol 0.29x
2026-10-06S2
Wk 14 · Vol 0.17x
2026-10-05S2
Wk 14 · Vol 0.22x
2026-10-01S2
Wk 14 · Vol 0.26x
2026-09-30S2
Wk 14 · Vol 1.83x
2026-09-29S2
Wk 13 · Vol 0.41x
2026-09-28S2
Wk 13 · Vol 0.94x
2026-09-25S2
Wk 13 · Vol 0.22x
2026-09-24S2
Wk 13 · Vol 0.13x
2026-09-23S2
Wk 13 · Vol 0.14x
2026-09-22S2
Wk 12 · Vol 0.22x
2026-09-21S2
Wk 12 · Vol 0.31x
Sector Peers — Stage 2All →
KOPRAN
wk 19 · -5.0% from hi
9.0
SMSPHARMA
wk 3 · -3.0% from hi
8.7
KILITCH
wk 2 · -1.7% from hi
8.7
BAFNAPH
wk 17 · 0.0% from hi
8.6
ZIMLAB
wk 21 · 0.0% from hi
8.3
Moving averages & range
50 DMA
₹116.8
200 DMA
₹100.8
52W High
₹137.7
52W Low
₹66.1
5D Low
₹112.9
Resistance levels (recent highs)
20d High
₹132.7
60d High
₹133.1
120d High
₹133.1
250d High
₹137.7
Next resistance
+14.9%
to 20d High
Ask the Market AI about THEMISMEDAsk →
Earnings Growth (YoY)
+1716.7%
Revenue -3.9%
Dividend Yield
0.47%
P/B 2.8
About this companyHealth Care· Pharmaceuticals

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients (APIs) and formulations used in various therapeutic areas, including anti-tuberculosis, analgesic and anti-inflammatory, analgesic and antispasmodic, analgesics, anesthesia, antacid-antiflatulent, anti-fungal, antibiotic, anti-diabetic, anti-emetic, anti-hypertensive, anti-allergic and anti-inflammatory, anti-allergic and appetite stimulant, anticoagulant, antifibrolytic, antimalarial, anti-muscarinic, antioxidant, calcium, cardiovascular, corticosteroid, electrolytes, expectorant, hematinic, hemostatic agent, hemostatic agent with anesthetic, hormones, immunomodulator with anti-viral, muscle relaxant, narcotic analgesic, neuropathy, nutraceuticals, PPI, probiotic, reversal for muscle relaxant, sedatives, skeletal muscle relaxant, skeletal muscle relaxant and analgesic and anti-inflammatory, vasodilator, vasopressors, and vitamins. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was founded in 1952 and is based in Mumbai, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-07. Past data patterns are not indicative of future results. This page is a data analytics tool only.